An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in Prostate Cancer Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces an extracellular matrix-Matrigel (ECM-M) culture model for better prostate cancer (PCa) cell tracking. The new model improves monitoring of androgen receptor (AR) activity and treatment responses at the single-cell level.
Area Of Science
- Oncology
- Cell Biology
- Biotechnology
Background
- Prostate cancer (PCa) exhibits significant intra-tumoral heterogeneity.
- Understanding dynamic cellular responses to treatment is crucial for improving outcomes.
- Current cell culture methods may limit detailed analysis of single-cell behavior.
Purpose Of The Study
- To develop and validate an improved cell culture model for prostate cancer.
- To enable dynamic, single-cell level monitoring of androgen receptor (AR) activity.
- To investigate heterogeneous responses to antiandrogen therapies in PCa.
Main Methods
- Introduction of an extracellular matrix-Matrigel (ECM-M) culture system.
- Utilizing bioluminescence single-cell imaging for cellular tracking.
- Employing the PSEBC-TSTA biosensor for AR activity assessment.
- Testing antiandrogen modulation across diverse PCa cell lines.
Main Results
- The ECM-M model significantly enhanced traceability and viability of PCa cells, especially poorly adherent ones.
- Robust single-cell tracking and AR activity monitoring were achieved without compromising substrate permeability.
- Heterogeneous antiandrogen responses were observed at the single-cell level.
- A correlation was found between non-responsive cell populations and drug IC50 values.
Conclusions
- The ECM-M culture model is effective for dynamic, single-cell analysis of PCa.
- This model facilitates precise characterization of androgen receptor inhibitor (ARi) responsiveness.
- It offers a promising approach to understand and predict heterogeneous treatment responses in cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.